MedTrace Logo

Real World Registry for Use of the Ion Endoluminal System

NCT06004440 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1301

Last updated 2026-04-24

No results posted yet for this study

Summary

The primary objective of this study is to evaluate the performance of the Ion Endoluminal System with real-world use for pulmonary lesion localization or biopsy.

Conditions

  • Lung Cancer
  • Multiple Pulmonary Nodules
  • Lung Neoplasms
  • Respiratory Tract Neoplasms
  • Thoracic Neoplasms
  • Neoplasms by Site
  • Neoplasms
  • Lung Diseases
  • Respiratory Tract Diseases

Interventions

DEVICE

Ion Endoluminal System

Subjects will under a planned procedure with the Ion Endoluminal System

Sponsors & Collaborators

  • Intuitive Surgical

    lead INDUSTRY

Principal Investigators

  • Janani Reisenauer, MD · Mayo Clinic

  • Michael Pritchett, DO, MPH · FirstHealth of the Carolinas

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-21
Primary Completion
2027-08-31
Completion
2028-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06004440 on ClinicalTrials.gov